Metals are nearly everywhere in our environment, and they are present naturally in our body and brain. They play important roles in our diet and they are essential to a variety of processes in our body and brain. A newly-published study that has received a lot of news coverage in the past couple days suggest a possible link between exposure to copper and beta amyloid, a protein many scientists believe play a critical role in developing Alzheimer’s disease. Here’s the analysis of this Alzheimer’s Association-funded study: Continue reading “Alzheimer’s research in the news: Copper” »
One of my favorite things to do as the CEO of the Alzheimer’s Association is present research checks to young scientists who are exploring innovative ways to tackle Alzheimer’s disease. I did just that yesterday at the UC Davis MIND Institute in Sacramento in the proud company of some of our most fervent supporters and volunteers.
The funding from the Alzheimer’s Association made possible by a generous gift from the Driskill Foundation, went to Izumi Maezawa, Ph.D., a researcher who started as a pharmacist in Japan before she became interested in Alzheimer’s research. Continue reading “New research funded by the Alzheimer’s Association yesterday” »
A U.S. Food and Drug Administration (FDA) advisory panel last week said that florbetapir (Amyvid), a radioactive dye proposed for use in Positron Emission Tomography (PET) to detect amyloid buildup in the brain, could be useful pending additional data analysis and training for physicians. The Alzheimer’s Association believes that further research is needed to understand the appropriate use of florbetapir-PET imaging — or any other imaging technology — in diagnosing Alzheimer’s. Read more here: http://bit.ly/huzUgV